1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Nivolumab as neoadjuvant (with chemotherapy) and adjuvant (as monotherapy) treatment for resectable non-small-cell lung cancer [ID6310]

In development [GID-TA11504] Expected publication date: TBC

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6310

  • Draft scope post referral PDF 200 KB 16 January 2024  
  • Draft matrix post referral PDF 185 KB 16 January 2024